Muscling their way into the food chain: Zebra mussels alter fish populations in the Hudson River
... pre-invasion conditions. Since the 1970s, utility companies on the Hudson River have gathered long-term data on juvenile fish populations as a condition of withdrawing cooling water from the river. These surveys began prior to the zebra mussel introduction, allowing for pre and post invasion assessment. Hudso...Institute for OneWorld Health nominated for the 2004 World Technology Awards
... - happy accidents - amongst those individuals and companies deemed by their peers to be the most innovative in the science and technology world. WTN also publishes "World Technology Intelligence, a collection of insights-from-the-innovators, largely written by and about current WTN members, as well as "World ...Commercialization deal boosts hope for new sickle-cell drug
... trials in 90 adults with sickle-cell disease. The companies will collaborate on multicenter Phase III trials, ...ortion of which will be paid to CHB and BIDMC. The companies will collaborate on the development and commercialization of ICA-17043 in Canada. ...New diagnostic technology helps justify earlier cataract surgery
...act patients experience. This will give insurance companies a reliable and widely accepted means of testing fo...ye Surgery Education Council. While some insurance companies will cover the cost of cataract surgery based on additional testing, there is no widely accepted tes...From science fiction to reality: Nanomedicine brings fresh hope to the medical world
...armaceutical, biopharmaceutical, and drug delivery companies are anything to go by, its prospects in the healthcare industry seem bright. Nanocrystal technology, for instance, is being used in drug formulation and the new chemical entities screening in the discovery phase of drug development. Quantum dot parti...Gene defects found in age-related macular degeneration
...distinctions are important, because pharmaceutical companies might already have a treatment that works for perhaps five percent of AMD patients. But if they treated a hundred patients with such a compound, they would conclude that it didn't work, because it wouldn't work for ninety-five percent of those patien...NIST study shows computerized fingerprint matching is highly accurate
...d 34 commercially available systems provided by 18 companies from around the world. NIST conducted the testing to evaluate the accuracy of fingerprint matching for identification and verification systems. While law enforcement agencies long have employed automated fingerprint matching devices, they are u...Report outlines steps needed to lessen smallpox threat
...ate engagement of biotechnology and pharmaceutical companies in the project. With the estimated price tag for developing two or three antiviral drugs at $1.5-$2.5 billion, it is likely that the government is going to have to consider new ways of operating with these companies. According to Harrison, one idea t...Confidentiality of genetic databases questioned by Stanford researchers
...ut the subject. Why worry? Lin said that insurance companies and employers potentially have an interest in learning whether a person is prone to certain illnesses, and that malevolent individuals might also try to seek out this type of information. So Lin, along with advisor Russ Altman, MD, PhD, associate pro...EC boosts European electron microscopy research
...icular interest to biotechnological and biomedical companies in the development of novel pharmaceuticals. Recognizing the emerging demand for this type of "Structural Genomics" research, the European Commission has opened opportunities for funding within its Sixth' Research Framework Programme. The 3D-EM Netwo...RICE gets $1.1m from DOD to study neurofibromatosis
...at regulate NF in humans. Ultimately, we hope drug companies can use these proteins as targets for new drugs that will limit or eliminate NF-tumor growth in people." Stern's team has received a new four-year, $1.1 million grant from the Department of Defense Neurofibromatosis Research Program to develop the fr...Cancer gene MYC emerging as key research target
...en addressed," McMahon says. Already biotechnology companies are developing cancer drugs directed at MYC, but current efforts involve drugs that would block all MYC function. Understanding the specific targets of MYC and their involvement in cancer should ultimately allow scientists to create better drugs that...$6 million appropriation to focus Sandia research on drinking water desalination, removal of arsenic
.... WERC will handle transfer of the technologies to companies that will commercialize them and sell them to the water utilities. The pilot-scale testing program, led by Sandia researcher Malcolm Siegel, will evaluate a variety of innovative approaches to reduce the cost of arsenic treatment for small communitie...Purdue yeast makes ethanol from agricultural waste more effectively
...ector of LORRE. "Iogen's efforts are beneficial to companies in Indiana and elsewhere in the United States by providing an industrial test bed for the fermentation part of the cellulose conversion technology, hence speeding its development for uses on a range of crops and crop residues once the other technolog...Mice with hyperactive Wnt10b gene eat all they want, but have half the body fat of normal mice
...on, cautions Longo and MacDougald. "Pharmaceutical companies are interested in the potential therapeutic role of Wnt genes in decreasing fatty tissue, but finding the right drug to selectively target this pathway without complications will be a considerable challenge," MacDougald says. "The goal of our researc...Underground carbon dioxide storage reduces emissions
...s of the country and the world, he said. "The oil companies have seen incremental production close to what they predicted and from the scientists' point-of-view, we've been able to see a response to our techniques and been able to monitor it very, very closely," said Rostron, the hydrogeology co-ordinator on ...ESA and EADS-CASA sign contract to build instrument for the SMOS mission
...now heads an industrial consortium of more than 20 companies from all over Europe, and is committed to construct the innovative MIRAS (Microwave Imaging Radiometer using Aperture Synthesis) instrument that will form the core of the SMOS mission. Scheduled for launch in early 2007, SMOS is the second Earth Ex...... is the long-term outcome of this?" he asks. While companies like Chromos are interested only in gene therapy, their work could have far-reaching consequences. Some researchers regard artificial chromosomes as the most promising method for germ-line genetic engineering of humans (New Scientist, 3 October 1998...Trapping carbon in soil key for protecting global food security, dealing with climate change
... take advantage of carbon trading markets utility companies and other industries that rely on fossil fuels can essentially buy carbon credits from farmers who have sequestered carbon in their soils. This ensures that CO2 in the atmosphere is kept at a minimum while farmers are encouraged to use methods that i...OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
...drugs in the developing world if biopharmaceutical companies considered innovative collaborations with nonprofi...s proven record of collaboration that enables drug companies to partner without compromising their profitability goals. "The benefits of such collaborations are...